Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
AGL Form 4 activity by transaction type, last 90 days
Form 4 transaction type
Transactions
Shares
Total value
Tax withholding / forfeiture
2
54
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AGL insider transactions (Form 4)
43
35 Form 4 filings on record, the earliest from Dec 11, 2024, newest first. Filing history page 1 of 2.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (shares): Restricted stock units that vest in three equal installments on each anniversary of May 7, 2026, subject to continued employment.
Footnote F3 (shares): Performance stock units may become vested subject to attainment during the three-year performance period (one-third vests if 30-trading-day weighted average price is equal or greater than $50, one-third vests if 30-trading-day weighted average price is equal or greater than… Full note on SEC EDGAR
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (price): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F3 (shares): Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F3 (shares): Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F3 (shares): Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F3 (shares): Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
Footnote F1 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
Footnote F3 (shares): Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
Footnote F1 (shares): This award was granted on April 14, 2023 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 9, 2026.
Footnote F2 (shares): The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2023 through December 31, 2025. Total attainment achieved was 42%.
Footnote F3 (price): Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date.
Footnote F4 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale.
Footnote F1 (shares): This award was granted on April 14, 2023 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 9, 2026.
Footnote F2 (shares): The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2023 through December 31, 2025. Total attainment achieved was 42%.
Footnote F3 (price): Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date.
Footnote F4 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale.
Footnote F1 (shares): This award was granted on April 14, 2023 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 9, 2026.
Footnote F2 (shares): The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2023 through December 31, 2025. Total attainment achieved was 42%.
Footnote F3 (price): Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date.
Footnote F4 (shares): Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale.
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.5671 to $0.6137, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
Footnote F1 (price): The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.6251 to $0.6321, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the… Full note on SEC EDGAR
agilon health, inc. (AGL) had 2 insider filings in the last 90 days, with the most recent on 18 August 2026. The full record for AGL runs to 35 Form 4 filings, the earliest from 11 December 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AGL stock?
No insider purchases of AGL were filed in the last 90 days. 10 purchases are on record for this company.
How many insiders are selling AGL stock?
No insider sales of AGL were filed in the last 90 days.
Where can I see AGL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AGL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.